The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma.

The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q46455135

about

Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients Recent advances in multidisciplinary management of hepatocellular carcinoma Treatment of hepatocellular carcinoma: Steps forward but still a long way to go Drug therapy for advanced-stage liver cancer Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Cancer and liver cirrhosis: implications on prognosis and management Transarterial Therapies for Hepatocellular Carcinoma Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort Predictors of repeat transarterial chemoembolization in the treatment of hepatocellular carcinoma Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥ 3 cm A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization.RMP predicts survival and adjuvant TACE response in hepatocellular carcinoma.Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.Management of Hepatocellular Carcinoma: Current Status and Future Directions.Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in Taiwan.Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study Novel implications in the treatment of hepatocellular carcinoma.Postsurgical treatment with adjuvant transarterial chemoembolization in patients with hepatitis B-related hepatocellular carcinoma: A strobe-compliant article.Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.Transarterial chemoembolization and bland embolization for hepatocellular carcinoma.Development of systemic therapy for hepatocellular carcinoma at 2013: updates and insights.Hepatocellular carcinoma review: current treatment, and evidence-based medicine.How to define transarterial chemoembolization failure or refractoriness: a European perspective Treatment of intermediate-stage hepatocellular carcinoma.Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment.Managing complications in cirrhotic patients Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma.Reassessing the boundaries of liver transplantation for hepatocellular carcinoma: Where do we stand with tumor down-staging?New concepts in embolotherapy of HCC.Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy.Review article: delivering precision oncology in intermediate-stage liver cancer.Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization.

P2860

Q26743666-6523BC16-DA51-4C7E-B9BD-4AFE9E95D767 Q26766707-8C579084-0822-42E3-8A1C-33A72072D384 Q26799469-1F161CE7-DC65-4610-809E-A88CFC4845C8 Q26863748-15D6B1F7-C081-4153-B164-C35A5C63007A Q26865456-768CCD99-D60F-4FC1-8990-8876395951CB Q27004410-02D79059-6AC4-45CE-8482-88F84A191F31 Q27022015-FC311C86-AA27-4C3A-B438-39F7C71497A2 Q28068579-E7C4E1EB-3EBB-414B-9C69-2A59A5EECF4F Q28072845-E7119267-2B60-46ED-AFFC-25A2192DE7F4 Q33572657-74710889-F07C-48ED-9EF5-74DF8DCF5EB3 Q34618735-4DEFA0C6-8EBC-47AF-BDAA-022AD2F8F600 Q34702094-610F7EE7-0BEA-4455-B45C-40E58BFA9FCC Q34986180-EB69CDA6-F6E8-48DA-B409-8676F4A9383F Q35546984-7C9B1A03-C2DE-4ECE-AF93-D41F84CD6A1D Q35550266-D64CEA36-138E-4DC8-8AC1-9084A5B68FF9 Q35720473-97C7793F-C066-48D5-B36C-429AA6D17921 Q35771842-CB5441F9-7BF8-432E-8D9F-65225AF723AD Q36416250-27E598EA-DA93-4CFB-84B4-E093D2D8C528 Q37114870-07DE1960-38B8-4B0F-9216-9E6540CB8E2F Q37328442-F309FC17-1888-417B-BA3E-299D584AC694 Q37537007-4D9842FE-27B2-4D1D-870D-9F8DC59A4202 Q37542835-3AE3D813-E7CA-49EF-9D3A-9A00D6FF0776 Q37552069-E1A4EA99-79EE-4DD3-B310-462D1A2E6622 Q37600883-C0F759C2-0F73-478F-8AE9-C561328F6CA4 Q37629021-38F6F1D0-4105-429A-B84F-45A00E07B9ED Q38201633-4CED1ED9-0AB5-4B0D-AD3B-DDA31E10E77A Q38201707-07915EA4-438B-400F-9CB6-B54EA95D5659 Q38207012-A991CA96-E86B-4869-AABB-F56F465B63D2 Q38221512-601E6EFE-D837-4ACB-8BA2-38E08D816A05 Q38236876-775DB816-DC9D-410E-A450-88DE814A9C3F Q38265024-801CC1CF-01AA-4CB4-A450-F6BA8F5C3ACC Q38344890-838404A0-2E29-46EA-A4E7-B1F0145082F6 Q38590448-1491BBF0-6FF5-4B6D-9D7F-1538A826570D Q38630820-DB997C14-E6D6-45BA-9823-2E21DA7DA7E8 Q38631276-EA2525C6-F872-4F36-82DF-A43E254E626B Q38904263-69D27CAB-E3F9-4B58-AB5F-F831A0985364 Q38923548-03CBCD9C-3A33-497D-8128-1F3B8C7F260B Q39261082-6A9D78CF-3D53-4F20-8639-5FC26B086A2A Q39754560-580D3A74-482D-45F9-8ECA-F02D7D507175 Q39830114-A0329EDD-7BB9-445B-8540-9739EAF5A8C0

P2860

The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q46455135

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

The ART of decision making: re ...... with hepatocellular carcinoma.

@en

The ART of decision making: re ...... with hepatocellular carcinoma.

@nl

type

label

The ART of decision making: re ...... with hepatocellular carcinoma.

@en

The ART of decision making: re ...... with hepatocellular carcinoma.

@nl

prefLabel

The ART of decision making: re ...... with hepatocellular carcinoma.

@en

The ART of decision making: re ...... with hepatocellular carcinoma.

@nl

P1433

Q46455135-006666FB-764E-4453-920B-872533BC14ED

P1476

Q46455135-69D49CDC-07E0-4D1B-89D1-FFBBAC4BCA9B

P2093

Q46455135-1DEE4CAC-CD48-4376-B049-0CDE7E430D5F

Q46455135-3341ACA1-0C07-4CB5-A105-A2381AE6D244

Q46455135-34C23529-A4D3-43F0-BE18-1882A1B06BFC

Q46455135-3BD42A9A-4C63-4DD9-B64D-ACFCBD4E71B6

Q46455135-4A86F848-E88E-43AF-A4FF-D1EC2C9BED40

Q46455135-D9DBF982-2F38-49AC-ADD0-7D4C4C98598C

Q46455135-DA234421-D0ED-4553-8BA2-28082890EBD8

Q46455135-DC48D39F-324F-414A-9A0D-1F2027B49964

P2860

Q46455135-028A76FA-E3F0-4187-9BAB-BA0B6EADAE5C

Q46455135-0358F370-C759-46CD-938A-B2D9302EA753

Q46455135-089FF6EE-77B8-40FC-8697-CA97495206FB

Q46455135-11D458FC-0826-49CD-8EF4-E882A0483143

Q46455135-237D7B2B-F5A1-402D-BFAD-C615989D0DB5

Q46455135-26337D02-3FF1-4DD8-836E-AA1FFA503185

Q46455135-30409FEE-C39B-4C6C-947E-3165C858E128

Q46455135-3445666D-E930-4E66-B047-B0ECAA9CADD4

Q46455135-572998EB-8870-476C-9C7D-053CB3A7F29B

Q46455135-5766EBA4-517F-4A4C-B1CA-98A335DDA369

P304

Q46455135-BB71BBFB-B570-48AA-9BF1-8118F4323A09

P31

Q46455135-8F159A14-266E-4095-95F5-2C47B838FCD8

P356

Q46455135-DE3004E7-2327-4856-9BE4-F02AD0456CEC

P407

Q46455135-50DE6DF4-CF13-4302-9D72-90A2CB5CDD3B

P433

Q46455135-D50A7A9B-A557-45D1-8D97-5B503D8481C2

P478

Q46455135-99D7EBC7-CFD5-442F-8186-CBAEACD1C942

P50

Q46455135-16DD055B-6498-4C5A-AA41-8E53AF9B885C

P577

Q46455135-78DA52E4-BF7C-4519-8FB0-C75811BC6CB6

P698

Q46455135-A6C3C695-EA55-40FF-8C5E-91FF31ED108C

P921

Q46455135-7E3376E9-4255-4A18-8806-F728047812F7

P356

P1433

P1476

The ART of decision making: re ...... with hepatocellular carcinoma.

@en

P2093

Christian Müller

http://www.w3.org/2001/XMLSchema#string

Florian Hucke

http://www.w3.org/2001/XMLSchema#string

Harald Heinzl

http://www.w3.org/2001/XMLSchema#string

Ivo Graziadei

http://www.w3.org/2001/XMLSchema#string

Matthias Pinter

http://www.w3.org/2001/XMLSchema#string

Michael Trauner

http://www.w3.org/2001/XMLSchema#string

Wolfgang Sieghart

http://www.w3.org/2001/XMLSchema#string

Wolfgang Vogel

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis.

Current strategy for staging and treatment: the BCLC update and future prospects.

P304

2261-2273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.26256

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Markus Peck-Radosavljevic

P577

2013-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23316013

http://www.w3.org/2001/XMLSchema#string

P921